Your browser doesn't support javascript.
loading
Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue.
Lapidari, Pietro; Djehal, Nardjes; Havas, Julie; Gbenou, Arnauld; Martin, Elise; Charles, Cecile; Dauchy, Sarah; Pistilli, Barbara; Cadeau, Claire; Bertaut, Aurélie; Everhard, Sibille; Martin, Anne-Laure; Coutant, Charles; Cottu, Paul; Menvielle, Gwenn; Dumas, Agnes; Andre, Fabrice; Michiels, Stefan; Vaz-Luis, Ines; Di Meglio, Antonio.
Afiliación
  • Lapidari P; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.
  • Djehal N; Univesità Degli Studi di Pavia, Pavia, Italy.
  • Havas J; Medical Oncology, Gustave Roussy, Villejuif, France.
  • Gbenou A; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.
  • Martin E; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.
  • Charles C; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.
  • Dauchy S; Bordeaux Public Health, Université de Bordeaux, U1219, Bordeaux, France.
  • Pistilli B; Département Interdisciplinaire de Soins de Support aux Patients en Onco-hématologie, Gustave Roussy, Villejuif, France.
  • Cadeau C; Medical Oncology, Gustave Roussy, Villejuif, France.
  • Bertaut A; Harvard Medical School, Boston, MA, USA.
  • Everhard S; Centre Georges-François Leclerc, Methodology and Biostatistic Unit, Dijon, France.
  • Martin AL; Unicancer, Paris, France.
  • Coutant C; Unicancer, Paris, France.
  • Cottu P; Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
  • Menvielle G; Medical Oncology, Institut Curie, Paris, France.
  • Dumas A; Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Andre F; ECEVE UMR 1123, Université de Paris, Paris, France.
  • Michiels S; Molecular Predictors and New Targets in Oncology, INSERM Unit 981, Gustave Roussy, Villejuif, France.
  • Vaz-Luis I; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France.
  • Di Meglio A; Inserm, University Paris-Saclay, Labeled «Ligue Contre le Cancer¼, Oncostat U1018, Villejuif, France.
Breast Cancer Res Treat ; 190(3): 517-529, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34559354
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapias Complementarias / Neoplasias de la Mama Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Terapias Complementarias / Neoplasias de la Mama Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Año: 2021 Tipo del documento: Article País de afiliación: Francia